Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 ASE专家共识：聚乙二醇过敏者超声增强剂的超敏反应

2021-07-08 美国超声心动图学会 J Am Soc Echocardiogr . 2021 Jul;34(7)

聚乙二醇超声增强剂

美国超声心动图学会是由致力于通过卓越的心血管成像技术为患者提供福祉的医疗机构和科学家组成。根据协会提供教育以改善临床结果的使命，本共识声明的产生是为了向我们的会员和所有超声心动图从业者提供信息和建议，

中文标题：

2021 ASE专家共识：聚乙二醇过敏者超声增强剂的超敏反应

英文标题：

Expert Consensus Statement from the American Society of Echocardiography on Hypersensitivity Reactions to Ultrasound Enhancing Agents in Patients with Allergy to Polyethylene Glycol

发布机构：

美国超声心动图学会

发布日期：

2021-07-08

简要介绍：

美国超声心动图学会是由致力于通过卓越的心血管成像技术为患者提供福祉的医疗机构和科学家组成。根据协会提供教育以改善临床结果的使命，本共识声明的产生是为了向我们的会员和所有超声心动图从业者提供信息和建议，以利于接受超声增强剂（UEAs）的患者的安全。具体而言，本文件就美国食品和药物管理局（FDA）产品安全报告系统MedWatch最近发出的关于UEAs中聚乙二醇（PEG）成分推定I型即时超敏反应的警报的临床影响提供专家意见。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ASE专家共识：聚乙二醇过敏者超声增强剂的超敏反应.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1a03f1c00213e2c8, title=2021 ASE专家共识：聚乙二醇过敏者超声增强剂的超敏反应, enTitle=Expert Consensus Statement from the American Society of Echocardiography on Hypersensitivity Reactions to Ultrasound Enhancing Agents in Patients with Allergy to Polyethylene Glycol, guiderFrom=J Am Soc Echocardiogr . 2021 Jul;34(7), authorId=0, author=, summary=美国超声心动图学会是由致力于通过卓越的心血管成像技术为患者提供福祉的医疗机构和科学家组成。根据协会提供教育以改善临床结果的使命，本共识声明的产生是为了向我们的会员和所有超声心动图从业者提供信息和建议，, cover=https://img.medsci.cn/2021725/1627227993000_2020535.jpg, journalId=0, articlesId=null, associationId=111, associationName=美国超声心动图学会, associationIntro=美国超声心动图学会（ASE ,American Society of Echocardiography）成立于1975年,是世界上最大的心脏影像国际组织。提供心血管系统超声图像、心脏超声心动图指南。, copyright=0, guiderPublishedTime=Thu Jul 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="bp3-card bp3-elevation-0 result-block" style="color: #182026;"> <div class="bp3-collapse"> <div class="bp3-collapse-body bp3-fixed-positioning-containing-block" aria-hidden="false"> <div class="common-result"> <div class="general-result"> <p>美国超声心动图学会是由致力于通过卓越的心血管成像技术为患者提供福祉的医疗机构和科学家组成。根据协会提供教育以改善临床结果的使命，本共识声明的产生是为了向我们的会员和所有超声心动图从业者提供信息和建议，以利于接受超声增强剂（UEAs）的患者的安全。具体而言，本文件就美国食品和药物管理局（FDA）产品安全报告系统MedWatch最近发出的关于UEAs中聚乙二醇（PEG）成分推定I型即时超敏反应的警报的临床影响提供专家意见。</p> </div> </div> </div> </div> </div>, tagList=[TagDto(tagId=9569, tagName=聚乙二醇), TagDto(tagId=71434, tagName=超声增强剂)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=71434, guiderKeyword=超声增强剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4094, appHits=60, showAppHits=0, pcHits=465, showPcHits=4034, likes=0, shares=6, comments=3, approvalStatus=1, publishedTime=Mon Jul 26 00:50:28 CST 2021, publishedTimeString=2021-07-08, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 25 23:48:03 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 12:09:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ASE专家共识：聚乙二醇过敏者超声增强剂的超敏反应.pdf)])
2021 ASE专家共识：聚乙二醇过敏者超声增强剂的超敏反应.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057480, encodeId=6d59105e480d3, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:59:14 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011323, encodeId=e27d101132332, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Wed Aug 25 12:39:55 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003115, encodeId=762610031154b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05975508286, createdName=ms5000002053971661, createdTime=Tue Jul 27 20:26:32 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057480, encodeId=6d59105e480d3, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:59:14 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011323, encodeId=e27d101132332, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Wed Aug 25 12:39:55 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003115, encodeId=762610031154b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05975508286, createdName=ms5000002053971661, createdTime=Tue Jul 27 20:26:32 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-08-25 贝宝聂是念来过倒5

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057480, encodeId=6d59105e480d3, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 13:59:14 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011323, encodeId=e27d101132332, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Wed Aug 25 12:39:55 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003115, encodeId=762610031154b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05975508286, createdName=ms5000002053971661, createdTime=Tue Jul 27 20:26:32 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-07-27 ms5000002053971661

    很好

    0

相关指南

2021 EACVI立场声明：聚乙二醇过敏患者的超声造影剂超敏反应

欧洲协会心血管影像协会(EACVI,European Association of Cardiovascular Imaging) · 2021-06-24

拓展阅读

2018 ASE指南：超声增强剂在超声心动图检查中的临床应用（更新版）

美国超声心动图学会(ASE,American Society of Echocardiography) · 2018-03-03

Baidu
map
Baidu
map
Baidu
map